Komori
Ulvac (6728) · PolicyAdvanced

Policy to Position Research and Development as an Important Pillar of Management

First written in FY2016. 17 of 36 entries say "Restated". Latest entry: FY2026.

36entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019-Q3RestatedFY2020-Q1 – FY2021-Q3AdvancedFY2021 – FY2024-Q2OtherFY2024-Q3 – FY20242016: 22017: 420172018: 420182019: 420192020: 320202021: 420212022: 420222023: 420232024: 320242025: 120252026: 32026
Same theme, other companies
Continued company-wide R&D activities and resource investmentA theme 202 companies write about · 0 as a headwind · 215 as a tailwind

54 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 217 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Total R&D expenses were ¥14,611 million, an increase of ¥620 million from the same period of the previous year. R&D expenses as a percentage of net sales fell 0.2 percentage points year on year to 5.4%. The company will continue investing to strengthen R&D capabilities, particularly in the semiconductor and electronics fields, to support further future growth.」

    R&D expenses increased from ¥13,991 million in the previous fiscal year to ¥14,611 million, indicating continued and increased R&D investment focused on the semiconductor and electronics fields.
  2. 2026-08-14RestatedRevisions to earnings forecasts

    「The Company will also strengthen research and development in growth areas. The necessary funds are expected to be allocated from cash inflows from operating activities and other sources.」

    The Company stated its policy of strengthening research and development in growth areas and funding it with cash inflows from operating activities and other sources.
  3. FY2026-H1RestatedAnnual report

    「Group-wide R&D activity spending for the six-month interim consolidated accounting period was ¥7,150 million. There were no material changes in the status of the group's R&D activities during the interim consolidated accounting period.」

    R&D activity spending was disclosed at ¥7,150 million, and it was stated that there had been no material changes in R&D activities.
  4. FY2025AdvancedAnnual report

    「Total R&D expenses were ¥13,991 million, an increase of ¥678 million from the same period of the previous year. R&D expenses as a percentage of net sales increased 0.5 percentage points from the same period of the previous year to 5.6%. The company will continue investing to strengthen R&D capabilities, particularly in the semiconductor and electronics fields, to support further future growth.」

    R&D expenses were ¥13,991 million, or 5.6% of net sales, indicating continued and increased R&D investment focused on the semiconductor and electronics fields.
  5. FY2024Continued decline in research and development expensesAnnual report

    「Total R&D expenses were ¥13,313 million, a decrease of ¥452 million from the same period of the previous year. R&D expenses as a percentage of net sales fell 1.0 percentage point from the same period of the previous year to 5.1%. Strengthening R&D capabilities is one of the key initiatives in the medium-term management plan, and the company continues to increase investment aimed at future growth.」

    R&D expenses decreased from ¥13,766 million in the previous fiscal year to ¥13,313 million, while the ratio to net sales fell from 6.1% to 5.1%. The company stated that it would continue investing in strengthening R&D capabilities and supporting future growth.
  6. FY2024-Q3Decline in R&D activity spendingAnnual report

    「Group-wide R&D activity spending for the cumulative first 3 quarters was ¥9,395 million.」

    R&D activity spending was ¥9,395 million, below the ¥10,415 million recorded in the same period of the previous year. However, it was stated that there had been no material changes in R&D activities.
  7. FY2024-Q2AdvancedAnnual report

    「Group-wide R&D activity spending for the cumulative second quarter was ¥6,188 million.」

    Cumulative R&D activity spending for the second quarter was ¥6,188 million, exceeding the ¥5,804 million recorded in the same period of the previous year. The increase in investment under the policy of making R&D a key pillar was reflected.
  8. FY2024-Q1AdvancedAnnual report

    「Group-wide R&D activity spending for the cumulative first quarter was ¥2,929 million.」

    R&D activity spending was ¥2,929 million, exceeding the ¥2,608 million recorded in the same period of the previous year. The increase in investment under the policy of making R&D a key pillar was reflected.
  9. FY2023AdvancedAnnual report

    「Total R&D expenses were ¥13,766 million, an increase of ¥3,425 million from the same period of the previous year. R&D expenses as a percentage of net sales increased 1.8 percentage points from the same period of the previous year to 6.1%. Strengthening R&D capabilities is one of the key initiatives in the medium-term management plan, and the company continues to increase investment aimed at future growth.」

    R&D expenses increased from ¥10,340 million in the previous fiscal year to ¥13,766 million, while the ratio to net sales rose to 6.1%. The company continued and expanded investment in future growth, with strengthening R&D capabilities positioned as a key initiative in the medium-term management plan.
  10. FY2023-Q3AdvancedAnnual report

    「Group-wide R&D activity spending for the cumulative first 3 quarters was ¥10,415 million.」

    R&D activity spending was ¥10,415 million, exceeding the ¥7,169 million recorded in the same period of the previous year. The increase in investment under the policy of making R&D a key pillar was reflected.
  11. FY2023-Q2AdvancedAnnual report

    「Group-wide R&D activity spending for the cumulative second quarter was ¥5,804 million.」

    R&D activity spending was ¥5,804 million, exceeding the ¥4,746 million recorded in the same period of the previous year.
  12. FY2023-Q1AdvancedAnnual report

    「Group-wide R&D activity spending for the cumulative first quarter was ¥2,608 million.」

    R&D activity spending was ¥2,608 million, up from ¥2,218 million in the same period of the previous year.
  13. FY2022AdvancedAnnual report

    「Total R&D expenses were ¥10,340 million, an increase of ¥1,965 million from the same period of the previous year. R&D expenses as a percentage of net sales fell 0.3 percentage points from the same period of the previous year to 4.3% due to the increase in net sales. Strengthening R&D capabilities is one of the key initiatives in the medium-term management plan, and the company continues to increase investment aimed at future growth.」

    R&D expenses increased by ¥1,965 million from the same period of the previous year to ¥10,340 million, indicating continued and expanded investment aimed at future growth.
  14. FY2022-Q3AdvancedAnnual report

    「The Group's research and development activities totaled ¥7.169 billion during the cumulative third-quarter period.」

    Cumulative R&D activity spending for the first 3 quarters was ¥7,169 million, exceeding the ¥5,771 million recorded in the same period of the previous year.
  15. FY2022-Q2AdvancedAnnual report

    「The Group's research and development activities totaled ¥4.746 billion during the cumulative second-quarter period.」

    Research and development activities totaled ¥4.746 billion, exceeding the ¥3.876 billion recorded in the year-earlier period and the ¥2.218 billion recorded in the previous cumulative quarter.
  16. FY2022-Q1AdvancedAnnual report

    「The Group's research and development activities totaled ¥2.218 billion during the cumulative first-quarter period.」

    Research and development activities totaled ¥2.218 billion, up from ¥1.839 billion in the year-earlier period. The company reported an increase in investment under its policy of making research and development a key pillar.
  17. FY2021AdvancedAnnual report

    「Total research and development expenses were ¥8.375 billion, an increase of ¥22 million from the year-earlier period. Research and development expenses as a percentage of sales increased 0.1 percentage points from the year-earlier period to 4.6% because sales declined. Although expenses remained roughly level with the year-earlier period as travel restrictions and other measures related to the impact of COVID-19 continued, the company continued to strengthen investment for future growth.」

    Research and development expenses increased by ¥22 million from the previous fiscal year to ¥8.375 billion, and the ratio to sales was 4.6%. The company explained that it would continue to strengthen investment for future growth.
  18. FY2021-Q3RestatedAnnual report

    「The Group's research and development activities totaled ¥5.771 billion during the cumulative third-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative third-quarter period.」

    There was no material change in the research and development policy, and research and development activities for the cumulative third-quarter period totaled ¥5.771 billion.
  19. FY2021-Q2RestatedAnnual report

    「The Group's research and development activities totaled ¥3.876 billion during the cumulative second-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative second-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key pillar, and that research and development activities totaled ¥3.876 billion for the cumulative second-quarter period.
  20. FY2021-Q1Research and development expenses declined, while the activity policy remained unchangedAnnual report

    「The Group's research and development activities totaled ¥1.839 billion during the cumulative first-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative first-quarter period.」

    The company stated that there had been no material change in its research and development policy, while research and development activities totaled ¥1.839 billion.
  21. FY2020Research and development expenses declined, but investment for growth continuedAnnual report

    「Total research and development expenses were ¥8.353 billion, a decrease of ¥856 million from the year-earlier period. Research and development expenses as a percentage of sales increased 0.3 percentage points from the year-earlier period to 4.5% because sales declined. Expenses decreased year on year owing to travel restrictions and other measures resulting from the impact of COVID-19, but the company continued to strengthen investment for future growth.」

    Research and development expenses declined from the previous fiscal year, but the ratio to sales was 4.5%, and the company explained that it would continue and strengthen investment for future growth.
  22. FY2020-Q2RestatedAnnual report

    「The Group's research and development activities totaled ¥4.361 billion during the cumulative second-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative second-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥4.361 billion.
  23. FY2020-Q1RestatedAnnual report

    「The Group's research and development activities totaled ¥2.122 billion during the cumulative first-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative first-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥2.122 billion.
  24. FY2019AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥9.209 billion」

    Under the policy of making research and development a key management pillar, research and development expenses increased from ¥8.293 billion in the previous fiscal year to ¥9.209 billion, and represented 4.2% of sales.
  25. FY2019-Q3RestatedAnnual report

    「The Group's research and development activities totaled ¥6.726 billion during the cumulative third-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative third-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥6.726 billion for the cumulative third-quarter period.
  26. FY2019-Q2RestatedAnnual report

    「The Group's research and development activities totaled ¥4.318 billion during the cumulative second-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative second-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥4.318 billion for the cumulative second-quarter period.
  27. FY2019-Q1RestatedAnnual report

    「The Group's research and development activities totaled ¥2.094 billion during the cumulative first-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative first-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities for the quarter totaled ¥2.094 billion.
  28. FY2018RestatedAnnual report

    「The Group positions research and development activities in next-generation and cutting-edge fields applying vacuum technology as a key management pillar, and during the fiscal year, research and development activities were conducted as follows, centered on the company.」

    The policy of making research and development a key management pillar was maintained in the full-year report. Total research and development expenses were stated to be ¥8.293 billion.
  29. FY2018-Q3RestatedAnnual report

    「The Group's research and development activities totaled ¥5.719 billion during the cumulative third-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative third-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥5.719 billion for the cumulative third-quarter period.
  30. FY2018-Q2RestatedAnnual report

    「The Group's research and development activities totaled ¥3.694 billion during the cumulative second-quarter period. There was no material change in the status of the Group's research and development activities during the cumulative second-quarter period.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development activities totaled ¥3.694 billion for the cumulative second-quarter period.
  31. FY2018-Q1RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」

    The company stated that there had been no material change in its policy of making research and development a key management pillar. Research and development expenses for the quarter were ¥1.787 billion.
  32. FY2017RestatedAnnual report

    「The Group positions research and development activities in next-generation and cutting-edge fields applying vacuum technology as a key management pillar, and during the fiscal year, research and development activities were conducted as follows, centered on the company.」

    The policy of making research and development a key management pillar was maintained in the full-year report, which stated that total research and development expenses were ¥6.891 billion.
  33. FY2017-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company reiterated that there had been no material change in the status of its research and development activities, and indicated no substantive change in its policy of making research and development a key management pillar.
  34. FY2017-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company reiterated that there had been no material change in the status of its research and development activities. No substantive change was indicated in the existing policy of making research and development a key management pillar.
  35. FY2017-Q1RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」

    The company stated that there had been no material change in the existing policy of making research and development a key management pillar.
  36. FY2016First statedAnnual report

    「The Group positions research and development activities in next-generation and cutting-edge fields applying vacuum technology as a key management pillar」

    Policy of making research and development a core management activity.
Moved together

"Strengthening the Financial Position and Improving the Equity Ratio" moved the same way as this thread, in the same document, in 7 of its 36 moves.

766555★123456
  1. ★This thread
  2. 1Strengthening the Financial Position and Improving the Equity Ratio7×
  3. 2Growth driven by semiconductor and electronic component manufacturing equipment6×
  4. 3Development of Equipment for Next-Generation Nonvolatile Memory and High-Performance Electronic Devices6×
  5. 4Establishing a structure to secure earnings reliably and steadily5×
  6. 5Production Engineering Innovation through Standardization of Manufacturing Equipment5×
  7. 6Bringing Low-Power, Long-Life Components to Market5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ulvac yet. It last moved in the Revisions to earnings forecasts of 2026-08-14: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Policy to Position Research and Development as an Important Pillar of Management | ULVAC, Inc. (6728) | Komori